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Smkakd meglumine w&m distrkoate s&ion IRe- 
nogratiw76), wbkh ccmtatns mkrobubbks measurkg 6.5 
modality. coronary arlericgraphy. provides qualitative pla- 
nar images of the lumen of major coronary arteries. it does 
not allow direct evaluation of myccardial tissue perfusion 
(2-l). Ncwcr imaging techniques (pasitron emisston tomog_ 
raphy and nuclear magnetic resonance imaging) now being 
developed will incorporate functional and antonic descrip- 
tors td facilitate the clinical evaluation of patients with 
ischemic heart disease (I). In general, myocardial perfusion 
patterns are anatomically defined by a complex vascular 
&work. Furthemmre, transmural myacardial perfusion is 
a&ted by regional stress, status of lhe underlying vascular 
anatomy and the viability of the cardiac tissue. Currently. 
Ihe degree of coronary artery stenosis and the analysis of 
regional wall motion by slondsrd two-dimensional echowr- 
diography do not adequately define the status of tissue blood 
Row and viability. An ideal tecmdque for assessing such 
perfusion would acquire data in a real time format while not 
disturbing either intrinsic y~scular flow characteristics or 
ventricular contramilc state. Experimental and clinical stud- 
ies suggest tha: contrast echoardiographic techniques may 
fulfill these criteria (S-27). 
Sonication ofmeglumine sodium diatrizoale solution (Re- 
norrafin-761 reoroduciblv creates sable microbubbles with 
an‘average dkneter skilar to that of red blood cells 
(5.6.2Sl. These microbubbles Row through the microvascu- 
lature without occlusion (29,30) and. a&ding to videoden- 
silometric analyses, reflect physiologic myocardial transit 
times (8,19). Studies of the &‘ects of sonicated Renogretin- 
76 on left ventricular contractility in dogs (14) have shown 
that the solution ralher than the presence of microbubbles 
atkts left ventricular function. Similarly, studier (I5,22) in 
patients receiving intracoronarv iniections of sonicated 
microbubbles of l&ografin-76 (I:5 to-2 ml) revealed that left 
ventricular contractile state wes not sianificanily altered by 
the presence of the sonic&d microbubbles. in addition. 
initial clinical studies using contrast ecltocardiography in the 
catheterization laboratory (20) and the operating room (21) 
have described the safety of injecting small volumes of 
agitated microbubble solutions into the sonic root or directly 
into the coronary art&~ to identify regional perfusion 
defects. 
However, as contrdst echocardiography becomes a useful 
procedure for assessing myocardial perfusion, it becomes 
necessary to establish references for blood Row distribution 
patterns in patients free of coronary artery disease. Accord- 
in&, this reQort correlates mvocardial wrfusion determined 
by~ontrast khocardiograph; with corkary artery anatomy 
as identified by arteriography in patients without significant 
coronary stenosis. 
Methods 
Patient selection. A total of 50 oatients oanicioated in a 
Protocol approved by the Univksity of Chic& Clinical 
Invwdpation Commktee for the study of myocardiot P&_ 
40” &ng Lm”tr*F* e&“cnr&ognphy dvring COmnYy zlne- 
riography. Patients diagnosed BS having critics1 aortic or 
mitral stenosis, critical and unstable ischcmic heart disease. 
a recent cerebrovascular accident (within 2 months) or 
endwdilir were excluded from the overall sludy. Of Ihe SO 
patients ewhmtcd, 18 were identified by efleriography BI 
having no significant coronary artery disease. These patients 
were used as a reference group to establish normal contrast 
perfusion data and constituted the study group for this 
report. 
Coronary arteriegraphy. Routine informed consent for 
cardiac catheterization was obtained and all standard preca- 
theterization procedures were followed. The eatheteriza- 
lions were performed utilizing the Seldinger technique with 
the patient resting on an angiographic cradle. The cineangio- 
grams were reviewed by en experienced angiogmpher using 
250% luminal narrowing as the criterion for significant 
coronary disease. The coronary artery system that gave rise 
to the posterior descending vessel was considered to he the 
dominant vessel. 
Two~dilmnsional contrast eehwrdiographic imagtng. The 
patient was draped on the catheterization table and rotated 
into the 30’ right anterior oblique position. Echocardio- 
graphic images were obtained &o& beneath the drapes 
overlying the patient’s chest and recorded on a one-halfinch 
(2.5 cm) VHS videotape system. The echocardiographic 
views as well as the number of injections performed for each 
view, depended on the quality of the two-dimensional echo. 
cardiographic images and the amount of time allotted for 
each study. According to our protocol. the ultrasound imag- 
ing time was limited to IO to I5 min for each study to avoid 
unnecessatily pmlonging the catheterization study. Two- 
dimensional echwrdiogmphic images were recorded before 
and during the inttacoronary injection of sonicated Renogra- 
fin-76 microbubbles. For each patient study, the ultrasoued 
control settings were adjusted to obtain the best visual image 
quality. The settings were not altered during the course of 
the study. No patient was prescreened for echocardio- 
graphic image quality before catheterization. 
Cotthpst agent prqmrpUon. Microbubble sobltions used 
as echocardiographic contrast agents were prepared in a 
sterile, standardized manner. The titanium horn of a sonica- 
tar unit (model 220 Heat Systems-Ultrasonics) was sterilized 
by soaking in B Food and Drug Administration-approved 
cold sterilant solution (Astracid-S). A 10 ml plastic syringe 
was filled with 8 ml of sterile Renogratin-76 and placed 
beneath the sonicator hum. The sonicator horn ~8% placed 
approximately one-halfinch beoeath the surface of the liquid 
and the enemy was turned on. The svrinae was then lowered 
from the horn to permit brief con& with the surface of the 
liquid. thus creating surface agitation. After 30 s, the salu- 
tion of sonicrded Renogratin-76 appeared franslucent. The 
opaque, white appearance of the liquid that accompanies 
prolonged surface r&&on was not present at the end of the 
ronic.tion pruccdure. The mew mbrabubblc & deter- 
mined by light micmscopy (51 was IO * 4 and by laser 
analysis (28) was 4.5 C 2.8 pm (Fig. I). Immediately after the 
energy was turned off, the syringe Plunger was reinselied 
and the Kdulion was ready for injection thmugh the anpio. 
graphic catheter. A totel of 1.5 to 2 ml of the sonic&cd 
Rensgrafin-76 solution was manually injected into the right 
or the left coronary artery and simultaneous two. 
dimensional echocardiographic imaging was performed. 
Visual analysts of contrast perfusion. All observers re- 
viewed the cemrest perfusion studies and two observers 
determined regional perfusion distribution. A paresternal, 
Flgurc 1. Laser analysis Frequency histogram of a representawe 
sample of sonicated Renogmfm-76. The frequency of ~ccwrence IE
ootheordinatesndthesizeofthemierobubble. inmicrans. isnnthr 
cross-sectional view obtained at the pauillaw muscle level 
was the most commonly recorded vikw’and ;herefore, was 
chosen for the regional perfusion analysis. The two- 
dimensional cross-sectional view was divided into IO regions. 
modified from the Revott of the American So&v of Ecbo- 
cardiography Committee on Nomenclature and.bandards 
(31) (Fii. 2). 
Regions I through 10 were labeled in a clockwise monmr 
as f&ws: anterior. anterolateral, postemlateral. pusterior. 
inferior, inferoseptal, mid-septal, anteroseptal and the an- 
lerolateral and posteromedial papillary muscles. For regions 
with echocardiographic “drop out:’ or loss of lateral border 
resolution, no assessment of perfusion was made. In areas 
supplied by both the lefl and right co..mary arteries, domi- 
nance of perfusion was established if >5G% of an area was 
estimated to be petised from the selective arterial injection. 
ReStlltS 
coronq slrleF’~tiJ to the ptiooa vilbovt .i8lli6-l 
comoq artery dL%mc. or ulc i.,itiat 5” patient, ,‘Ud,nl, I8 
did not have rignikmt coronary artery disease. Four of 
these I8 patients were excluded from further analysis-three 
because B parasternal, cross-sectional two-dimensional 
echocardiosraphic view was not available and one beczxxe 
the conUas1 effecl was inadequate. (The latter patient was 
the first subject studied in our promcot and the microbubble 
solution was diluted before the intracoronary injcctiana.) A 
right dominant curtmary system was nuted in I2 of the 14 
patients without signiticant coronary Avery disease: the 
remaining 2 patients demonstrated a left dominant system. 
In several al the patients classified as having a right domi- 
nant system, the left circumflex coronary artery suppiied 
arterial branches to the pOster&tcral sspect of the left 
ventricle. No patient studied developed complications dur- 
ing or after the catheterization procedure. In patients in 
whom hemodynamic variables were assessed throughout he 
contrast ecbocardiograpbic portion ofthe study, only minor, 
transient aiterations were noted in the heart rate. blocd 
pressure and electrocardiogram (ECG) during the intracoro- 
nary injections. Our findings. previously reported 
(12-15.25). are consistent with recent clinical data from 
other laboratories (20-2224.26.27). 
Contrast eebacardiogspby. The contrast echocardio- 
graphic perfusion studies in the I4 patients employed P total 
of 70 intracomnary injections (I .5 to 2 ml each) of sonicated 
Renogralin-76. The number of injections per patient ranged 
from four to eight, and the echocardiographic views obtained 
per patient varied between one and three. with the paraster- 
nst 10”$~.x:S and crorr-secrionnl &WS used in 64 ,O,%> af76 
ir+xtionr. 
Of the II regions visually analyzed (IO regions in I4 
patients). 3 regions in one patient were considered inade- 
quate for analysis purpoxs. In three patients. no right 
coronary arted injection of microbubbles was wfumted 
because of difficulty in attaining a stable catheter position. 
Accordingly. perfusion characteristics wer: analyzed only 
for the left coronary injections in those three patients. 
Awssment of regknll myocwdiil prfttsii in rienB 
without si@knt eonmary artery dka.w Wig. 3). Regional 
perfusion based on videointensity was analyzed in each 
patient using a two-dimensional echocardiognphic paraster- 
Figure 5. Twodimensio”al echccnrdiograms for a representative 
patient study. A, Easeline image (no microbubbles present in the 
myocardial tissue). 8. image obtined during a sekclive right 
coronary injection of ronicated micrcbubbleo resulting in cotirast 
e”ba”cement in the inferior and interosepti regions. c, bna*e 
ablained after a IefI coronary injection of microbubbler dcmon- 
strati”g perfusion oftbe a”,Cd”r. lateral and posterior regions. 
“al cross-sectional view obtained at the papillary muscle 
level. Figure 3 illustrates the cross-sectional echocardio- 
graphic video images from one patien\ study. From the still 
frame photographs. it was possible lo identify the endwar- 
dial and epicardial borders as well as the two papillary 
muscks. The baseline image is shown in Figure IA. Aftcra 
1.5 to 2 ml injection of sonicaled Renografm-76 microbub- 
bles i”\o the right coronary artery (Fig. 3B). dense white 
opacificalion was noted in the inferoseptal and inferior 
regions. The posteromedial papillary muscle was also visu- 
ally enhanced after the injection. Figure 3C demonstrates the 
tissue distribution of the microbubbles after a I.5 to 2.0 ml 
left main intracoronary injection of sonicakd Renografin-76; 
the areas of echo contrast enhancemenl from the left core- 
nary injection wmplemenled those regions not receiving 
microbubble perkion after the right coronary injection. The 
lefl iniection oerfosed the anteroseotal, anterior. anterolat- 
ml. ~os~erol&er~l and posterior r&ions. The anterolateral 
papillary muscle was also perfused from the left coronary 
injection. 
Right dominant coronary artery systeto (Fig. 4). In all 12 
oatients with a right dominant coronaw swtem. the left 
iorunary arte  &used the auteroseptal, anterior, autero- 
lateral, pasterolateral and posterior regions of the left “en- 
tricle. The autemlateral papillary muscle wes consistently 
perfused by the lefl corottary distribution. The right coro- 
nary artery perfused the inferior and inferoseptaiareas in 
8% of cases, the mid-septal area in 17% and the portem- 
medial papillary muscle in 42%. 
Lefl domioant cmmmy artery sWem. In the two patients 
with ttormal coronary arteries and a left dominant system, 
bath papillary muscles were supplied from the left system. 
However, the inferior and inferoseptal regions were supplied 
from the left coronary system in one patient and from the 
right coronary system in the other patient. 
Variability of perfusion. Of the 14 patients analyzed, 8 
had two or more (range two to five) sequential intracomnary 
injections of sonic&& Renografin-76 with simultaneous two- 
dimensional echocardiograms performed at the cross- 
sectional papillary muscle level. The perfusion distribution 
patterns noted atIer each injection were separ&ely analyzed 
by two observers several months later. There was no varia- 
lion noted in the regional patterns in any case when serial 
injections were compared. 
Discussion 
R&maJ caroouy perfusicm p&tents awssed by contrast 
eehueardiugraphy. This report describes the successful clin- 
ical use of real lime contrast echoczdiogmphy to assess 
myocardial perfusion in humans at the time of coronary 
arterioaruokv. These studies demorstated the feasibilitv of 
usit!! &t&t echocardiography with sonicated Rettogr&- 
76 to identifv reatonal oerfusion at the oaoilla;v muscle level .- . . 
within myocardial tissue. The myocardial p&usion data 
available in this study were not obtained using arteriography 
or conventional two-dimensional echacardiography. 
Overall, in the patients without significant coronary ar- 
tery disease, the variation noted in the regional bkmd Row at 
the level of the papillary muscle was lirxited primarily to the 
interventricular septum. the inferior wall and the pasterome- 
dial papillary muscle. However, in au individual patient, the 
actual extent of perfusion could not readdy be predicted 
lrom the cpicardkd coronary anaromy. 
The variauon noted when comparing anatomy and petiu- 
sion among patients may arise from a variety of factors: the 
simplified coronary anatomic description used; the presence 
of collateral vessels; the influence of non-ECG-pted. mau- 
ual mtracoronary injections, or simply B variation in individ- 
ual perfusion patterns. However, the importance of identi- 
fying regtonal perfusion patterns at the time ai coronary 
arteriography needs to be stressed. Today, a detailed anal- 
ysis of myocardial perfusion has not been possible with 
coronary arteriogmpky or standard two-dimensional ecko- 
cardiographic images. By combining these two imaging 
modalities at the time of cardiac catheterization and intro- 
ducing microbubbles os au intravascular. nond#usable 
trace; a real time, tmuugruphic perfusion index can be 
developed. Thus, despite the complex vuscular network 
within the mywardium and the variations in trausmunl flow 
characteristics due to coronary stenosis. myocardial infarc- 
tion or interventional therapy, contrast eckocardiographic 
techniques may prove to be a valuable tool for the immediate 
assesrment of myocardial blood flow. 
Previous studks. Before the development of sonicated 
microbubble ultraround agents. contrast echocardiography 
employed hoed-agitated microbubbles that were relativelv 
la&variable ii size and unable to pans through the 
capillary bed without o&ruction (29.30.32). Despite the 
large size of microbubbles in hand-agitated contrast sokt- 
tious. no histologic abnormalities attributable to vasculur 
OCCLUSION m the brain. heart or hidney have been noted in 
animal studies 03). In htalan stttdies. hand-agitated micro- 
bubbles have been injected from both the left and rigkt sides 
of the heart sbtce 1968 fbr the qualitative assewuent of 
valvular regur&ation (34), cavity dimensions (35) and intra- 
cardiac Ekuntr (L&38). These studies have been perfoned 
without siguiticaut clinical complications (20.21,3&39). 
However, the recent development of small. uniform-sized 
souicatcd Renozratin-76 micmbubbles has allowed trackina 
of echoretIe&- tncers through the tuicrovawdatur~ 
within physiologic transit times (8.18,19). We have previ- 
ously determmed the effects of sonicated microbubbles on 
len ventricular contractibty in animals using a sensitive 
noninvasive index of myocardial function (14). Alterations in 
contractile state noted in that study were attributed to the 
particular carrier solution or to the presence of the larger 
hand-agitated bubble solution and not to the presence of the 
sonicated micmbubbles of Renografin-76 solution (23). This 
work receot!y has been expanded into clinical trials (IS). In 
humans, intracoronary injections of small volumes (1.5 to 2 
ml) of sonicated microbubbles in Renugraftn-76 did not 
adversely effect cootrnctility. This war true even though 
intracoronary injection of large volumes (7 to 9 otl) of 
Renogratin-76 transiently depressed wntractile state. 
Methndoloeic eotwideratioos. For this initial study of ner- 
fusion in pr&tts at the time of cardiac catheterization; we 
limited the total echocardiogmphic imaging time to approx- 
imately IO to IS min. This was done to avoid unnecessary 
delays in wrfortning the catheterization procedure. There- 
fore, we did not attempt to fully characterize the left 
ventricular myocardiol oerfusion. Our efforts revealed that 
the parastern~l short-&is view was the most commonly 
obtained image and, hence. we chose to analyze only that 
level of perfusion in each patient. Because of the clinical 
utility ofassersing mywxdial perfusion in conjunction with 
coronary aogiogrnphy, in subsequent studies we have ex- 
tended the imaging time to permit more views of the tnyo- 
eardium. 
With regard to the image quality and yield of the paroster- 
nal short-axis views, contrast echocardiogrnphic techniques 
offer several advantages over those of standard two- 
dimensional echocardiograms. First, the use of microbub- 
blesenhancesthe signal to noise ratiu;thus thequality ofthe 
two-dimensional image is improved, permitting clearer iden- 
lidcation of endocardial and epicardial surfaces. Conse- 
quently, tneasurements of wall thickness and cavity dimen- 
sions are easily txrfomted. The enhanced ultrasound sirnals 
should complement and promote the use of qusntit%ive 
two-dimensional echocardiography for the evaluation of left 
ventricular performa~e (40.41). In addition. the enhanced 
border identification may facilitate the use of cornputer- 
assisted, automated edge detection algorithms, ulti&ely 
permitting three-dimensional reconstruction of perfusion 
wtthin the myocardium. 
Second, using contrast echocardiograuhic technisues in 
conjunction with coronary angiography, it is possible to 
“target” areas of interest in the myocardium. Suecilicaliy, il 
a clinical question exists regarding the perfusion distribuiion 
associated with the left anterior descending artery, the 
ultraround investigation can be directed to the anteroseptal. 
anterior and anterolateral regions of the myocardium. By 
identifying the region of interest we can improve the yield ol 
clinical information. using cootrast echocardiography nt the 
time of the cardiac catheteiiration. In future studies. b) 
devoting more time to ultrasuund imaging in the catheterize. 
lion laboratory. we could obtain several views of the myo. 
canlium and. consequently. more thoroughly characterize 
the myocardial blood Row. 
With regard to rhe individual variabilily associared with 
intromyocardial bbod,%w. several facrors may contribute. 
The nonstandardized manual intracoronarv iniections of 
contrast agents may have resulted in the.rec&itment of 
capillary vessels, thus disturbing the native blood flow 
pattcros within the tiwe. The use of a hyperosmalar, 
biologically active solution (Reno&ut-76) may alter the 
autoregulation of the vasculature. In addition, the timing of 
the injection often extended beyond a single cardiic cycle. 
Thus, the spatial, temporal heterogenicity of regional flow is 
likely to he altered (42). In the future, a” ECG-gated, 
volume- and pressure-controlled mechanical injector may 
reduce the effects of the injection process oo the native 
coronary blood Row (43) and the use of newly developed 
air-filled. albumin microspheres hould reduce the variability 
and biologic activity of the current ultrasound conlra~l 
agents w-46). 
Cunclusiuns. This initial study suggests that contrast 
echocardiowauhv utilizine. sonicated Renoarafin-76 micro- 
bubbles is a safe, effic&ous and physiologic means of 
determining regional myoeardial p&ttsion. Further valida- 
lion and testing will be required to determine the clinical 
ulilily of perfomting contrast echocardiographic studies to 
as&s tisiue blood kow. With the incr&& clinical use of 
interventional therapies. the need to demonstrate the sevcr- 
ity of coronary artery lesions and their physiologic signifi- 
cance is critical (I). This study suggests that important 
clinical issues regarding coronary artery anatomy and myo- 
cardial perfusion can be addressed in a single setting. Used 
at the time of cardiac atheterization during coronary angio- 
plasty or cardiac revascularization surgery, contrast echo. 
cardiography may provide no improved understanding of the 
physiology of blood flow within the myocardium. Subse- 
quent therapy and management decisions could then be 
approached in a quantifiable tttnnner, perhaps ultimately 
resulttrig in improved tnanagement of paticnts with ischemic 
heart disease. 
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